E-Therapeutics

Based on advances in chemical biology and network science, network pharmacology is a distinctive new approach to drug discovery. It involves application of network analysis to determine the set of proteins most critical in any disease, and then chemical biology to identify molecules capable of targeting that set of proteins. By addressing the true complexity of disease and by seeking to harness the ability of drugs to influence many different proteins, network pharmacology differs from conventional drug discovery approaches, which have generally been based on highly specific targeting of a single protein. Network pharmacology has the potential to provide new treatments for complex diseases where conventional approaches have failed to deliver satisfactory therapies.

Type
Public
HQ
Long Hanborough, GB
Founded
2003
Size (employees)
27 (est)
E-Therapeutics was founded in 2003 and is headquartered in Long Hanborough, GB

E-Therapeutics Office Locations

E-Therapeutics has an office in Long Hanborough
Long Hanborough, GB (HQ)
Blenheim Office Park, 17 Fenlock Rd

E-Therapeutics Data and Metrics

E-Therapeutics Financial Metrics

GBP

Net income (FY, 2017)

(13.1 m)

Market capitalization (25-Jul-2017)

32.9 m

Closing share price (25-Jul-2017)

0.1

Cash (31-Jan-2017)

14 m
E-Therapeutics's current market capitalization is £32.9 m.
GBPFY, 2014FY, 2015FY, 2016FY, 2017

Pre tax profit

(6.1 m)(9.8 m)(11.3 m)(16.2 m)

Net Income

(5 m)(7.8 m)(8.8 m)(13.1 m)
GBPFY, 2014FY, 2015FY, 2016FY, 2017

Cash

43.1 m33.8 m24.8 m14 m

Current Assets

45 m37.4 m28.8 m17.7 m

PP&E

121 k96 k64 k51 k

Goodwill

496 k637 k740 k156 k

Total Assets

45.6 m38.2 m29.6 m17.9 m

Accounts Payable

402 k601 k562 k889 k

Current Liabilities

1 m1.1 m1.2 m2 m

Total Liabilities

1 m1.1 m1.2 m2 m

Retained Earnings

(5 m)(7.8 m)(8.8 m)(13.1 m)

Total Equity

44.6 m37 m28.4 m16 m

Financial Leverage

1 x1 x1 x1.1 x
GBPFY, 2014FY, 2015FY, 2016FY, 2017

Cash From Operating Activities

(5.7 m)(9.9 m)(9.2 m)(9.4 m)

Cash From Financing Activities

39 m77 k12 k13 k

Income Taxes Paid

1.1 m2 m2.5 m3.1 m
Y, 2017

Financial Leverage

1.1 x

E-Therapeutics Operating Metrics

E-Therapeutics's Projects Launched was reported to be 12 in FY, 2016, which is a 100% increase from the previous period
FY, 2015FY, 2016

Projects Launched

612

    E-Therapeutics Market Value History

    Traffic Overview of E-Therapeutics

    E-Therapeutics Company Life and Culture

    You may also be interested in